chrisvoncsefalvay/vaers-outcomes huggingface dataset:
got the vaccine and has been with shingles/Suspected vaccination failure; has been with shingles; she has been in bed wth shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and bedridden. On an unknown date, the outcome of the vaccination failure, shingles and bedridden were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and bedridden to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 21-MAY-2022 Reporters comment:  The case was reported by the patient's neighbor via interactive digital media and described the occurrence of suspected vaccination failure. After receiving Shingles vaccine, the patient got shingles on her face and she had been in bed with shingles for days at the time of reporting. The patient asked her doctor why she got shingles if she was vaccinated for it and he said that it happens. The reporter stated that, the shot did not stop you from getting shingles. Additional supportive information: This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory test confirming shingles were unknown at the time of reporting. Follow up would not be possible as contact details were not provided.
Pt was asleep and started to have uncontrolable spasms, became stiff and was not responding to mom's voice.  Mom reports this lasted a 'few minutes'.  Then became responsive but confused, was able to drink water.  Pt felt hot but mom didn't have a thermometer.  No urinary or stool accident.  Slept fine afterwards and was acting fine the next morning when he was in our office.  No fever or signs of illness.
Was diagnosed with COVID-19 two days after first dose of the vaccine.; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Was diagnosed with COVID-19 two days after first dose of the vaccine.) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Was diagnosed with COVID-19 two days after first dose of the vaccine.). The patient was treated with PREDNISONE for COVID-19, at an unspecified dose and frequency. At the time of the report, SARS-COV-2 TEST POSITIVE (Was diagnosed with COVID-19 two days after first dose of the vaccine.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Jan-2021, SARS-CoV-2 test: positive (abnormal) positve.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient also used V pack as treatment.
PATIENT RECEIVED THE SHINGRIX VACCINE ON 4/24/18. PATIENT SAID A WEEK LATER THEY DEVELOPED TINGLING IN THEIR LEG/FOOT WHICH LATER DEVELOPED INTO BLISTERS. THEY WENT TO SEE THE DOCTOR ON FRIDAY 5/4/18, WHOM DIAGNOSED THEM WITH SHINGLES.
Vertigo starting 4 days after the shot with no other symptoms up to then.  The vertigo exhibited as nausea when moving head that resulted in vomiting.  Any movement of the head results in dizziness and nausea.  No other symptoms in the rest of the body, no fever, no headache.
Shot given in L deltoid/ IM early AM. By 5pm arm 1" below shot site swollen, red, warm painful.
Similar to rash that appeared after 1st dose, except 2nd occurrence was smaller area, lighter in color and lasted a shorter time.  Following 2nd dose, rash appeared on abdomen approx 2 1/2 inch dia above navel, consisting of raised red dots with bright pink backgrounds.  Very little to no itching.  No significant fever (less than 1 deg above normal range), and no other reactions.  Rash cleared to about 95% gone by evening of 6/6/21.
Pain was worse on the left side; Went from her shoulder to her joint to her back and up to her neck; Tenderness under the arm which may be related to the lymph nodes.; Pain occurs at random times and it makes it difficult for her to sleep; Vaccination site is still bruised; Muscle pain primarily in the arm; Felt pain in her arm from the injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain was worse on the left side), PAIN IN EXTREMITY (Went from her shoulder to her joint to her back and up to her neck), TENDERNESS (Tenderness under the arm which may be related to the lymph nodes.), INSOMNIA (Pain occurs at random times and it makes it difficult for her to sleep) and ADMINISTRATION SITE BRUISE (Vaccination site is still bruised) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced INJECTION SITE PAIN (Felt pain in her arm from the injection). On an unknown date, the patient experienced PAIN (Pain was worse on the left side), PAIN IN EXTREMITY (Went from her shoulder to her joint to her back and up to her neck), TENDERNESS (Tenderness under the arm which may be related to the lymph nodes.), INSOMNIA (Pain occurs at random times and it makes it difficult for her to sleep), ADMINISTRATION SITE BRUISE (Vaccination site is still bruised) and MYALGIA (Muscle pain primarily in the arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and EUGENOL, MENTHOL, METHYL SALICYLATE (HEAT) at an unspecified dose and frequency. At the time of the report, PAIN (Pain was worse on the left side), PAIN IN EXTREMITY (Went from her shoulder to her joint to her back and up to her neck), TENDERNESS (Tenderness under the arm which may be related to the lymph nodes.), INSOMNIA (Pain occurs at random times and it makes it difficult for her to sleep), ADMINISTRATION SITE BRUISE (Vaccination site is still bruised), INJECTION SITE PAIN (Felt pain in her arm from the injection) and MYALGIA (Muscle pain primarily in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  The patient experienced pain which has been there for the last 2.5 weeks.
Approximately 5 minutes after receiving Gardasil #2, patient was lightheaded, very pale, clammy skin, listless. Given cold water, reclined with legs increased and felt better after 10 minutes.
Patient came to the pharmacy looking to receive a 2nd Dose in the Primary Moderna series. Our pharmacist gave the patient a dose of the Moderna Bivalent booster. To our knowledge the patient has had no issues with the dose. We plan to follow up and advise the patient to receive the second dose of monovalent Moderna as soon as possible. We will also follow up with the patients physician to coordinate care through them. Protocols and training have been reemphasized to ensure this issue does not happen again.
Cellulitis left deltoid; T 100.6 F; headache; localized swelling; erythema; raised rash 8-10 mm at injection site. Treated with Keflex.
Weakness in right shoulder, right deltoid not activating at all, potential axillary nerve damage
intense flu like symptoms.  muscle aches and fatigue.   had to stay in bed for just over a week.
vomiting, sleepiness, loss of appetite, elevated temperature (100.7 degrees), sore arm
Tuesday afternoon I started to feel bad and I went out that night to my book club. Wednesday morning i was achy and 100.4 fever. I tested that night it was positive. I called my doctor to see if i should tax Paxlovid. Thursday morning i had a telehealth visit and she gave me Paxlovid and started that night and took that for 5 days and that night i went for a walk. And the following Tuesday i tested negative.
pt recv vax & devel a red,hard,raised,painful area @ the inj site;this is one of two patients from this site who exp above reaction p/receiving lot number 4948003;
Stomach Cramps - Diarrhea - vomit for about 5 hours - Next two days anything I ate gave me stomach cramps - I thought I had a ulcer - the third day I was fine no cramps after eating - no treatment was on the weekend.
Kinrix given instead of Pediarix; Kinrix given to a 11-month-old; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 11-month-old female patient who received DTPa-IPV (Kinrix) for prophylaxis.   Concomitant products included DIPHTHERIA VACCINE TOXOID + PERTUSSIS VACCINE ACELLULAR + TETANUS VACCINE TOXOID (INFANRIX).   On 10-MAR-2023, the patient received Kinrix. On 10-MAR-2023, an unknown time after receiving Kinrix, the patient experienced wrong vaccine administered (Verbatim: Kinrix given instead of Pediarix) and inappropriate age at vaccine administration (Verbatim: Kinrix given to a 11-month-old). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 06-Apr-2023 The nurse reported that she was not sure what dose number this was for the patient but reported that the patient received Infanrix series 2 along with a full panel of vaccines (unknown vaccines).  The reporter did not had a lot or any further information for this administration.  On 6th January 2023, the patient was a new patient to their practice, and she had no previous information about the patient. The reporter consented to follow-up. The patient received a dose of Kinrix instead of Pediarix at an inappropriate age, which led to wrong vaccine administered.
Immediately after injecting, patient's arm swelled and became hard (at injection site and surrounding area). Ice was applied and swelling went down, but did not go away, neither did hardness. Patient was monitored  for approxiamately 30 minutes and showed no signs of trouble swallowing or breathing. Patient immediately went home and is being monitored by her husband. She is continuing to apply ice while at home. Patient and her husband are aware to call 911 if she experiences any changes.
Right arm, redness, itchiness, swelling. patient received mcv4 vaccine on right arm . Mom states with immediate redness, swelling, warmth and itchiness that same night. No sob, no difficulty breathing. Provider instructions: diphenhydramine 10ml (12.5mg/5ml) po q6 hrs x 2 days okay to continue with ice to affected area. Hand hygiene , limit scratching to prevent any open /broken skin, secondary infection. Return to clinic if no improvement in 2 days
High pitched scream x several hours beginning at 1:30PM.  Pt inconsolable for several hours.  No fever.  No irritation at injection sites.
pt recvd vax & w/in 1 hr lethargic & refused to walk; 10PM, head was floppy 5AUG all 4 extremities paralyzed (flaccid); MD visit hospitalized in ICU; MRI showed massive edema of spinal cord from medulla down; dx transverse myelitis;
Vaccine received on 3/18/2021  Brain fog and dizziness started on 3/28/2021 Progressively worsened until first intense vertigo episode on 5/3/2021. After this date, dizziness is constant. (1st) ENT prescribed meclizine, it did not help. Also prescribed prednisone, 21 days of strong dosage followed by 10 days tapering off. It helped a little, but did not fix anything. Episodes seemed to be worse around menstrual cycle, lasting days. Audiologist did balance test on Aug 19, 2021 and found uncompensated vestibular dysfunction and CNS involvement. Referred to PT for Vestibular Rehab (did 4 weeks), it didn?t help. Referred to neurologist; he was useless. Currently waiting to see 2nd neurologist. Ever since the balance test on Aug 19, I have had 3-5 intense vertigo and inner ear episodes every single week. Every. Single. Week.
Patient had a positive COVID PCR on 10/03/2021 after receiving both vaccine doses
The day after, I thought I was getting symptoms, I woke up, I was taking a shower, I was shaking, I couldn't stand, I laid down in my bed for about 30 minutes; that past, but for the rest of the day I was very weak. I tested positive for COVID-19, that evening, I took PCR test, they put me in PAXLOVID, they symptoms were gone, but I have heart issues, my pressure went up, I had a CT, ECHO of my heart.
Had the normal vaccination symptoms Friday (10/1) and Saturday (10/2) that included fever, headache, tiredness, and fatigue. On Monday (10/4), I developed chest pain and shortness of breath. I also had a fever, chills, extreme fatigue and tiredness. These symptoms lasted for approximately 2 weeks.  After the chest pain mostly subsided, I have continued to experience fatigue and my heart will flutter. I was prescribed prednisone on 10/7/2021.
swelling gets bigger; hard; swollen; big as a quarter; itchiness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INFLAMMATION (swelling gets bigger), VACCINATION SITE SCAR (hard), VACCINATION SITE PRURITUS (itchiness), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE INDURATION (big as a quarter) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN + HIDROCLOROTIAZIDA                                              for hypertension) for Hypertension, VITAMIN C [ASCORBIC ACID] (VITAMIN C [ASCORBIC ACID]                                                     for supplemental purposes) for Supplementation therapy.    On 18-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness). On 24-Mar-2021, the patient experienced VACCINATION SITE SCAR (hard), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE INDURATION (big as a quarter). On 25-Mar-2021, the patient experienced VACCINATION SITE INFLAMMATION (swelling gets bigger). At the time of the report, VACCINATION SITE INFLAMMATION (swelling gets bigger), VACCINATION SITE SCAR (hard), VACCINATION SITE PRURITUS (itchiness), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE INDURATION (big as a quarter) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment medication was provided.
On 17-AUG-2018, the patient was vaccinated with an improperly stored dose of GARDASIL 9 lot # R004689; expiration date: 29-NOV-2020 or lot # R006689; expiration date: 29-NOV-2020 (dose and route of administration were not reported) for prophylaxis, which had a temperature excursion of 47 degrees F to 77 degrees F (56F) for 15 days on unspecified dates. There were no previous temperature excursions and no digital data logger involved in recording the temperature excursion. No adverse effects were reported. This is one of several reports from the same source; Sender's Comments: US-009507513-1808USA012996: US-009507513-1809USA006251: US-009507513-1809USA006252: US-009507513-1809USA006253: US-009507513-1809USA006254: US-009507513-1809USA006255: US-009507513-1809USA006257: US-009507513-1809USA006258: US-009507513-1809USA006259: US-009507513-1809USA006260: US-009507513-1809USA006261: US-009507513-1809USA006262: US-009507513-1809USA006263.
A non-serious spontaneous report of 65 year old patient received a dose of H1N1 LAIV was received from a pharmacist concerning a 65-year-old female. Neither relevant medical history nor concomitant medications have been reported for this patient. On 04-Dec-2009, the patient received H1N1, Intranasal, for an unknown indication. There was no adverse event associated with this medication error therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33-year-old male patient received BNT162b2 (BNT162B2), on 07Apr2021 as dose 2, single (Lot number: EW0150), in left arm and on 18Dec2021 as dose 3 (booster), single (Lot number: 33030BD) at the age of 33 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Lactose, reaction(s): "Known allergies: Lactose". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Aug2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: COVID rebound 4 days after completing Paxlovid.
Information has been received from a Licensed Visiting Nurse concerning a 60 day old male with no pertinent medical history and no drug allergies who on 26-OCT-2010 was vaccinated with the first dose of ROTATEQ by oral administration (lot number reported as 668337/0524Z). There was no concomitant medication. On 26-OCT-2010 the patient developed an abdominal rash 12 hours after administration of ROTATEQ. The patient was evaluated in the office on 29-OCT-2010. He was found to have a temperature of 100.2 F and a widespread rash on his abdomen. No therapy was prescribed. Lab diagnostics studies were not performed. At the time of report, the outcome was unknown. Additional information has been requested.
muscle ache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle ache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L2OA) for COVID-19 vaccination.     Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced MYALGIA (muscle ache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 08-Feb-2021, MYALGIA (muscle ache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
hives, wheezing, emesis, sneezing, coughing, airway swelling, facial edema p/vax w/in 10 mins of vax; anaphylaxis;
Fever 103; headache; swollen/very painful lymph node under armpit; swollen/very painful lymph node under armpit; pain irradiated into chest; body aches; chills; booster; This is a spontaneous report from a contactable consumer. This 35-year-old female consumer (patient) reported that she received 3rd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, FH8020) booster dose single on 09Nov2021 02:30 PM at left arm for COVID-19 immunization at the age of 35 years old. Medical history included known allergies; Sulfa meds. Historical vaccine included 1st dose of BNT162B2 (lot EN6202) on 02Mar2021 at 07:00 AM at left arm and 2nd dose of BNT162B2 (lot EN6203) on 23Mar2021 07:30 AM at left arm both for COVID-19 immunization at the age of 34 years old.  Concomitant drugs included diazepam, isopropamide iodide (VALTRAX), ethinylestradiol, norethisterone acetate (JUNEL) and cetirizine hydrochloride (ZYRTEC ALLERGY). The patient experienced fever 103, swollen/very painful lymph node under armpit, pain irradiated into chest, body aches, chills, headache on 09Nov2021 08:00 PM. No treatment was received for the events. The outcome of the events was not resolved.   Follow-up attempts are completed. No further information is expected.
pt vax dtp/ovp. pt devel fever 102 degF, local reaction consist. of pain, swelling, increased warmth at injec site, and screaming episode, duration of illness - 2 dys.
Patient's arm turned red and warm to touch. Began to swell. She said it was also itchy at the site of the ZOSTAVAX injection. Dr gave her KEFLEX and BENADRYL.
No adverse event; Past lot that had been expired, administered to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Past lot that had been expired, administered to patient) and NO ADVERSE EVENT (No adverse event) in a 72-year-old male patient who received mRNA-1273 (Spikevax) (batch no. O70H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Past lot that had been expired, administered to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Past lot that had been expired, administered to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Past lot that had been expired, administered to patient).  ID number was reported as 80777027398.  Patient age was reported as 77 years and 11 months.  Concomitant product use was not provided by the reporter.  It was reported that patient were administered Moderna vaccine between 08-Apr-2022 and 15-Dec-2022.  Treatment information was not provided.
Information has been received from a healthcare worker referring to unknown number of patients (unknown age and gender). The patients were vaccinated with improperly stored M-M-R II (dose, dose #, lot #, route and application site were not reported), since 01-OCT-2015. No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
He got his vaccine, he went home and within an hour he had fatigue, runny nose and then it seemed like he was getting joint pain, back pain and a headache/jaw pain.  His breathing got short, chest discomfort.  He went to the ER and was informed that it was muscular.  His heart rate was climbing at times, up and down and would get up and move around.  He went to his cardiologist and felt that he was throwing T-signs on a scan.  They did a catheterization and they did not say too much.  He then started with skin rashes, "moon bumps", which he took pictures of and had swelling around his eyes as well.  He had pain in his ear, jaw and his teeth.   He was trouble with his teeth with them chipping and some of his fillings were falling out.  Recently he had a problem with skin lesions/sores and has scars when he had previous signs of this after the first vaccine J&J.   He still has fatigue and went to PenDental due to his teeth and has to readjust his bite and do some surgery in his jaw.   He was down for 8 weeks with the J&J vaccine, and had circulations with the 2nd vaccine and has problems with movement and fatigue.  He may also have Raynaud's disease from the vaccine as well.    He had welts, skin lesions but not like Stevens-Johnsons.  He was put on a steroid ointment that he used, which did help.  He also went to a dermatologist who told him to take a antihistamine.    He did not have problems with breathing or chest problems prior to the vaccines.
Rash devel 4th day p/inject & may well be roseola; Had feveer but was not measured; rt thigh was tender & swollen; Seen by MD, rash disappeared by 11AUG91; Seen in 12AUG91 rash cleared, still has some swelling @ inject site;